QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Aprea Therapeutics (APRE) Insider Trading & Ownership

$5.35
-0.26 (-4.63%)
(As of 02:53 PM ET)

Aprea Therapeutics (NASDAQ:APRE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
20.90%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$86,719.14
Number Of
Insiders Selling
(Last 12 Months)
0
Get APRE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aprea Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

APRE Insider Buying and Selling by Quarter

Aprea Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/13/2024Bernd R SeizingerDirectorBuy6,860$7.29$50,009.40  
3/13/2024John P HamillCFOBuy1,010$7.29$7,362.90  
3/13/2024Oren GiladCEOBuy2,000$7.29$14,580.00  
6/6/2023Bernd R SeizingerDirectorBuy4,068$3.63$14,766.84  
(Data available from 1/1/2013 forward)

APRE Insider Trading Activity - Frequently Asked Questions

Who is on Aprea Therapeutics's Insider Roster?

The list of insiders at Aprea Therapeutics includes Bernd R Seizinger, Eyal C Attar, Gregory Alan Korbel, John P Hamill, Lars B Abrahmsen, and Oren Gilad. Learn more on insiders at APRE.

What percentage of Aprea Therapeutics stock is owned by insiders?

20.90% of Aprea Therapeutics stock is owned by insiders. Learn more on APRE's insider holdings.

Which Aprea Therapeutics insiders have been buying company stock?

The following insiders have purchased APRE shares in the last 24 months: Bernd R Seizinger ($64,776.24), John P Hamill ($7,362.90), and Oren Gilad ($14,580.00).

How much insider buying is happening at Aprea Therapeutics?

Insiders have purchased a total of 13,938 APRE shares in the last 24 months for a total of $86,719.14 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:APRE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners